高端疫苗生物製劑股份有限公司
高端疫苗生物製劑股份有限公司是一家生物技術藥物公司，在台灣從事疫苗、生物藥劑及醫療器材之研發與批發。研發產品包括：腸病毒 A71 疫苗（處於臨床三期，用於治療伴隨嚴重併發症的腸病毒感染）、四價流感疫苗（處於臨床三期）、登革熱疫苗（已完成臨床二期）、抗呼吸道融合病毒 (RSV) 藥物（處於臨床一期）以及新冠肺炎 (COVID-19) 疫苗。公司成立於 2012 年，為基亞生物科技之子公司，總部位於台灣新竹縣。
今日下跌 1.64%。該股 RSI(6) 為 46.2，處於中性區間，短線無明顯超買超賣訊號。股價站上5日、60日、120日均線，跌破20日均線。KD 指標中性（K=25.4）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | -752 | 0 | +23 | -736 |
| 09-23 | +1,372 | 0 | +39 | +1,349 |
| 09-22 | +210 | 0 | +86 | +266 |
| 09-21 | +44 | 0 | +37 | -16 |
| 09-18 | -1,077 | 0 | +154 | -994 |
| 09-17 | +57 | 0 | +17 | +54 |
| 09-16 | -260 | 0 | +359 | +85 |
| 09-15 | +466 | 0 | +23 | +436 |
| 09-14 | +715 | 0 | +35 | +696 |
| 09-11 | -500 | 0 | +136 | -552 |
| 09-10 | -4,744 | 0 | +296 | -5,001 |
| 09-09 | +2,097 | 0 | +213 | +2,127 |
| 09-08 | +658 | 0 | +124 | +691 |
| 09-07 | +939 | 0 | +173 | +835 |
| 09-04 | -681 | 0 | +56 | -747 |
| 09-03 | +533 | 0 | +94 | +529 |
| 09-02 | -785 | 0 | +44 | -797 |
| 09-01 | -122 | 0 | +130 | -296 |
| 08-31 | -1,968 | 0 | +20 | -2,064 |
| 08-28 | +1,434 | 0 | +167 | +1,209 |
| 08-27 | +3,896 | 0 | +204 | +3,477 |
| 08-26 | +2,463 | 0 | +286 | +2,349 |
| 08-25 | +1,153 | 0 | +79 | +817 |
| 08-24 | +49 | 0 | +34 | -332 |
| 08-21 | +137 | 0 | +199 | -96 |
| 08-20 | +669 | 0 | +32 | +184 |
| 08-19 | -99 | 0 | +72 | -270 |
| 08-18 | +1,802 | 0 | +59 | +1,421 |
| 08-17 | -621 | 0 | +26 | -646 |
| 08-14 | -650 | 0 | +19 | -701 |
| 08-13 | +1,293 | 0 | +22 | +1,129 |
| 08-12 | -350 | 0 | +28 | -371 |
| 08-11 | +434 | 0 | +22 | +163 |
| 08-10 | +615 | 0 | +5 | +448 |
| 08-07 | +1,203 | 0 | +78 | +949 |
| 08-06 | -1,320 | 0 | +106 | -1,419 |
| 08-05 | +1,821 | 0 | +68 | +1,734 |
| 08-04 | +160 | 0 | +19 | +158 |
| 08-03 | +407 | 0 | +36 | +409 |
| 07-31 | -332 | 0 | +26 | -325 |
| 07-30 | +33 | 0 | +41 | +48 |
| 07-29 | -161 | 0 | +49 | -138 |
| 07-28 | -528 | 0 | +12 | -538 |
| 07-27 | -461 | 0 | +38 | -483 |
| 07-24 | +215 | 0 | +26 | +225 |
| 07-23 | -829 | 0 | +11 | -934 |
| 07-22 | +285 | 0 | +10 | +273 |
| 07-21 | -397 | 0 | 0 | -413 |
| 07-20 | +264 | 0 | +28 | +244 |
| 07-17 | -217 | 0 | +6 | -252 |
| 07-16 | -127 | 0 | +20 | -164 |
| 07-15 | +982 | 0 | +196 | +1,127 |
| 07-14 | -553 | 0 | +55 | -545 |
| 07-13 | -797 | 0 | +53 | -771 |
| 07-09 | -73 | 0 | +4 | -85 |
| 07-08 | -174 | 0 | +38 | -152 |
| 07-07 | +363 | 0 | +19 | +339 |
| 07-06 | +731 | 0 | +136 | +491 |
| 07-03 | +1,060 | 0 | +28 | +1,071 |
| 07-02 | -51 | 0 | +5 | -55 |
| 07-01 | -109 | 0 | +26 | -109 |
| 06-30 | -640 | 0 | +18 | -695 |
| 06-29 | +842 | 0 | +19 | +814 |
| 06-26 | +142 | 0 | +17 | +151 |
| 06-25 | -203 | 0 | +4 | -216 |
| 06-24 | +201 | 0 | +2 | +202 |
| 06-23 | -160 | 0 | +14 | -172 |
| 06-22 | -50 | 0 | +28 | -50 |
| 06-18 | -405 | 0 | +37 | -409 |
| 06-17 | -157 | 0 | +134 | -117 |
| 06-16 | -157 | 0 | +16 | -162 |
| 06-15 | -47 | 0 | +26 | -34 |
| 06-12 | +59 | 0 | +6 | +60 |
| 06-11 | -538 | 0 | +47 | -532 |
| 06-10 | +328 | 0 | +22 | +324 |
| 06-09 | -881 | 0 | +33 | -887 |
| 06-08 | +399 | 0 | +39 | +366 |
| 06-05 | -1,558 | 0 | +319 | -1,566 |
| 06-04 | +916 | 0 | +128 | +943 |
| 06-03 | -199 | 0 | +17 | -202 |
| 06-02 | -554 | 0 | +20 | -549 |
| 06-01 | +260 | 0 | +41 | +273 |
| 05-29 | +240 | 0 | +28 | +250 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 3872 萬 | -11.0% | -7.9% |
| 2026/03 | 4353 萬 | +72.0% | -4.6% |
| 2026/02 | 2531 萬 | -31.8% | -25.2% |
| 2026/01 | 3710 萬 | -12.5% | +3.2% |
| 2025/12 | 4238 萬 | +21.6% | +14.5% |
| 2025/11 | 3484 萬 | -50.1% | -1.8% |
| 2025/10 | 6979 萬 | -33.0% | +23.9% |
| 2025/09 | 1.04 億 | +127.8% | -14.9% |
| 2025/08 | 4574 萬 | -18.2% | -17.6% |
| 2025/07 | 5592 萬 | -1.0% | -14.0% |
| 2025/06 | 5647 萬 | +21.8% | +12.4% |
| 2025/05 | 4638 萬 | - | -44.8% |